R 299.9831 Hazardous waste pharmaceuticals and hazardous waste ENDS; shipping non-creditable hazardous waste from a healthcare facility or ENDS retailer or evaluated hazardous waste pharmaceuticals from a reverse distributor.

Rule 831. (1) A healthcare facility or ENDS retailer shall ship non-creditable hazardous waste and a reverse distributor shall ship evaluated hazardous waste pharmaceuticals off- site to a designated facility in compliance with all the following requirements: (a) Before transporting or offering for transport off-site, the following pre-transport requirements: (i) Package the waste in accordance with the applicable DOT regulations on hazardous materials under 49 CFR parts 173, 178, and 180. (ii) Label each package in accordance with the applicable DOT regulations on hazardous materials under 49 CFR part 172, subpart E. (iii) All the following marking requirements: (A) Mark each package of non-creditable hazardous waste in accordance with the applicable DOT regulations on hazardous materials under 49 CFR part 172, subpart D. (B) Mark each container of 119 gallons or less with the following words "HAZARDOUS WASTE—Federal Law Prohibits Improper Disposal. If found, contact the nearest police or public safety authority, EGLE, or the EPA"; the healthcare facility, ENDS retailer, or reverse distributor’s name, address, and site identification number; and the manifest tracking number accordance with the requirements of 49 CFR 172.304. (C) Lab packs that will be incinerated in compliance with 40 CFR 268.42(c) are not required to be marked with hazardous waste numbers, except D004, D005, D006, D007, D008, D010, and D011, where applicable. A nationally recognized electronic system, such as bar coding or radio frequency identification, may be used to identify the hazardous waste number. (iv) Placard or offer the initial transporter the appropriate placards according to DOT regulations for hazardous materials under 49 CFR part 172, subpart F. (b) The manifest requirements of R 299.9309, except for the following: (i) A healthcare facility shipping non-creditable hazardous waste pharmaceuticals is not required to list all applicable hazardous waste numbers in item 13 of the manifest. (ii) A healthcare facility shipping non-creditable hazardous waste pharmaceuticals shall write the word "PHARMS" in item 13 of the manifest. (2) A healthcare facility, ENDS retailer, or reverse distributor that exports non-creditable hazardous waste or evaluated hazardous waste pharmaceuticals is subject to R 299.9314. (3) Any person that imports non-creditable hazardous waste or evaluated hazardous waste pharmaceuticals is subject to R 299.9314. A healthcare facility, ENDS retailer, or reverse distributor shall not accept imported non-creditable hazardous waste or evaluated hazardous waste pharmaceuticals unless they have an operating license or interim status under these rules that allows them to accept hazardous waste from off-site. Editor's Note: An obvious error in R 299.9831 was corrected at the request of the promulgating agency, pursuant to Section 56 of 1969 PA 306, as amended by 2000 PA 262, MCL 24.256. The rule containing the error was published in Michigan Register, 2025 MR 8. The memorandum requesting the correction was published in Michigan Register, 2025 MR 13.